This gives rise to the possibility that EGR-1-dependent signaling loop and the TNFα-EGR-1–CYP19–estrogen-EGR-1 axis could result in persistent activation of estrogen production, thereby facilitating the development of ER-positive breast cancer in the tumor microenvironment. The gene discussed is ESR1; the disease is breast carcinoma.